WealthStone »

Biogen Idec shares owned by WealthStone

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by WealthStone from 13F filings

Historical chart of WealthStone investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by WealthStone consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by WealthStone

Quarter filed Position value Share count Share price at filing
2021-03-31 $228k 818 278.73
2019-06-30 $701 3 233.67

More positions owned by WealthStone

Ishares TRUST Equities (MUB)
Ishares Core S&P 500 ETF Equities (IVV)
Ishares BarCap Aggregate Bond Index Equities (AGG)
Ishares Russell 1000 Index Equities (IWB)
Goldman Sachs Acss Invmt Grd Corp Bd ETF Equities (GIGB)
Vanguard Corp Bond Etf Equities (VCIT)
Microsoft Corp. Equities (MSFT)
Amazon Equities (AMZN)
Ishares Core S&P Small-Cap ETF Equities (IJR)
Ncino Equities
Facebook Inc Class A Equities (META)
Shyft Group Equities (SHYF)
Google Inc Class A Equities (GOOGL)
Johnson & Johnson Equities (JNJ)
Google Inc Class C Equities (GOOG)

View all positions for WealthStone

Top funds holding Biogen Idec

Vanguard Group
PRIMECAP Management Company
BlackRock
Wellington Management Company
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
Van Eck Associates Corp.
Morgan Stanley
T. Rowe Price Associates
ClearBridge Advisors
Legal & General Group
Northern Trust
Bank of New York Mellon
Dimensional Fund Advisors

View all funds holding Biogen Idec